📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist (2021)

First Author: Pickford P

Attributed to: RAMP2 and the glucagon receptor: important in the pathogenesis of non-alcoholic fatty liver disease? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.03.02.433157

Publication URI: http://dx.doi.org/10.1101/2021.03.02.433157

Type: Preprint